Zobrazeno 1 - 10
of 43
pro vyhledávání: '"P. Chinet-Charrot"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Anne Floquet, Hugues Bourgeois, K. Hamond, P. Chinet-Charrot, D. Lebrun, J.F. Heron, F. Meyer, Claude Leroy, Florence Joly
Publikováno v:
International Journal of Gynecological Cancer. 16:77-82
A retrospective study evaluating the efficacy and tolerability of epirubicin-ifosfamide (EI) in patients with relapsed advanced ovarian cancer (ROC) after prior chemotherapy was conducted. A total of 93 patients received epirubicin (50 mg/m(2), day 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc53322137c5760c774316a882403452
https://doi.org/10.1111/j.1525-1438.2006.00288.x
https://doi.org/10.1111/j.1525-1438.2006.00288.x
Autor:
Gilles Calais, P. Clavère, P. Maillart, Thierry Delozier, Moïse Namer, J.L Wendling, P.L Etienne, C. de Gislain, F. Turpin, Gérard Ganem, Elisabeth Luporsi, D Tigaud, Daniel Serin, Gilles Romieu, G. Prévost, Simon Schraub, P Marti, P Chinet-Charrot, Jean-Christophe Eymard, P. Colin, P Soler-Michel, Pierre Pouillart, Véronique Trillet-Lenoir
Publikováno v:
European Journal of Cancer. 37:1132-1140
This comparative phase III trial of mitoxantrone+vinorelbine (MV) versus 5-fluorouracil+cyclophosphamide+either doxorubicin or epirubicin (FAC/FEC) in the treatment of metastatic breast cancer was conducted to determine whether MV would produce equiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6d6841c80c8c7a85604f58a507d08d8
https://doi.org/10.1016/s0959-8049(01)00093-4
https://doi.org/10.1016/s0959-8049(01)00093-4
Autor:
Thierry Lesimple, J.L. Achard, D. Lebrun, Bruno Coudert, Jean-Paul Guastalla, P. Vennin, J. Blumberg, N. Callet, P. Chinet-Charrot, Catherine Lhommé, S. Ispas, J.E. Couette, Elisabeth Luporsi, J. Chauvergne
Publikováno v:
Gynecologic Oncology. 75:187-193
The objective of this phase II multicenter study was to assess the efficacy and tolerance of triptorelin (a sustained-release LHRH agonist) in advanced or recurrent endometrial cancer. A total of 101 monthly intramuscular injections were administered
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f01875b2e8842e91c00354799f26b5db
https://doi.org/10.1006/gyno.1999.5538
https://doi.org/10.1006/gyno.1999.5538
Autor:
Martine Delannes, M. Hay, P. Cellier, A. Goupil, P. Chinet-Charrot, Alain Gerbaulet, R. Rozan, B. Giraud, D. Donnarieix, J.E. Couette, G. Chaplain, B. Hassel, E. Albuisson, B. Castelain, P. Mere, S. Hoffstetter, J. Pigneux
Publikováno v:
Radiotherapy and Oncology. 36:83-93
Although cancer of the penis is a rare disease, we have collected 506 cases through a multicentric study. In the present study we analyse the results obtained from 259 patients treated by interstitial brachytherapy from 1959 to 1989. Among the 259 pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cbf07e1c4db4e525ea5451b875a94be
https://doi.org/10.1016/0167-8140(95)01574-z
https://doi.org/10.1016/0167-8140(95)01574-z
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
P. Biron, J. D'Anjou, Ch. Chevreau, Jean-Léon Lagrange, V. Beckendorf, A. Delobel-Deroide, J. Merrier, J. Dumont, P. Chinet-Charrot, A. Ramaioli, J.-M. Karsenty, R.-M. Parache, Ch. Theodore, M.J. Terrier-Lacombe, C. Chassagne, J.P. Droz
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 12(9)
Primary non-Hodgkin's lymphoma of the testicle is rare. We analysed cases treated in French anticancer centres from 1969 to 1995. All cases were reviewed and classified according to the R.E.A.L. Classification. Eighty-four cases were included in this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0aca9f8504ca4b5f820b98501ecf1174
https://pubmed.ncbi.nlm.nih.gov/11697846
https://pubmed.ncbi.nlm.nih.gov/11697846
Autor:
J. Macé-Lesec'h, D. Lebrun-Jezekova, P. Chinet-Charrot, J.F. Héron, P. Kerbrat, Florence Joly, H. Crouet, Catherine Lhommé, D. Vennin, M. Rios, J. Chauvergne, A. Goupil, F. Mayer
Publikováno v:
Gynecologic oncology. 78(3 Pt 1)
The aim of this study was to evaluate the impact of platinum dose intensity on pathological response rate and overall survival in patients with advanced ovarian adenocarcinoma.Between February 1992 and December 1996, 195 previously untreated patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efcca81484d0a251fd3aba0fde595c31
https://pubmed.ncbi.nlm.nih.gov/10985895
https://pubmed.ncbi.nlm.nih.gov/10985895
Publikováno v:
Bulletin du cancer. 83(4)
The objective of this phase II study was to determine the efficacy and toxicity of a combination of carboplatin and etoposide as salvage treatment, in previously treated patients with persistent or recurrent ovarian cancer following first-line cispla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::29a1334174268295e2893ca45e68e449
https://pubmed.ncbi.nlm.nih.gov/8680083
https://pubmed.ncbi.nlm.nih.gov/8680083
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.